Our vision is to heal patients and free them from the devastating effects of osteoarthritis by restoring hyaline cartilage and reducing inflammation using our proprietary induced pluripotent stem cell (iPSC) derived hyaline cartilage cell therapy.
We are developing an allogenic, off the shelf, injectable, regenerative therapy and aim to reach patients as early as possible to potentially restore joint function and prevent the need for joint replacement surgery.
Company Details
- Employees
- 5
- Address
- Minneapolis, Minnesota, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.sarcioinc.com/
- Keywords
- Vancouver.
- HQ
- Minneapolis, Minnesota
Sarcio Inc. Questions
Sarcio Inc.'s website is https://www.sarcioinc.com/
Sarcio Inc.'s LinkedIn profile is https://www.linkedin.com/company/sarcio-inc
Sarcio Inc. has
5 employees.
View email and phone details for 5
employees at Sarcio Inc..
Sarcio Inc.'s industry is
Biotechnology Research
Sarcio Inc.'s top competitors are
Novoclade,
Smart2mrw,
Sarcio Solutions Inc.,
Sarcio,
Abreos Biosciences,
Purebiox,
Aurora Concussion Therapy Systems, Inc.,
Priogen Corp,
Alp Business Consult,
Bioxstem.
Sarcio Inc.'s categories are Biotechnology Research
